ClinicalTrials.gov
ClinicalTrials.gov Menu

Temperature Control During Dialysis Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00438295
Recruitment Status : Completed
First Posted : February 22, 2007
Last Update Posted : September 15, 2015
Sponsor:
Information provided by:
Regional Hospital Holstebro

Brief Summary:
The purpose is to measure the effect of glucose in the dialysis water on blood pressure, pulse rate, and plasma glucose with and without body temperature control

Condition or disease Intervention/treatment Phase
Renal Failure, Chronic Procedure: temperature control Phase 4

Detailed Description:
To clarify the influence of temperature in dialysis water on blood pressure and vasoactive hormones

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 18 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effect of Temperature Control During Dialysis Treatment With Glucose in Dialysis Water in Patients With Chronic Renal Failure
Study Start Date : August 2006
Actual Study Completion Date : May 2007



Primary Outcome Measures :
  1. Effect of temperature control on blood pressure, pulse rate and blod glucose during dialysis treatment


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Age > 18 years,
  2. both men and women,
  3. chronic renal failure and dialysis treatment for at least three months

Exclusion Criteria:

  1. Heart failure,
  2. Lung insufficiency,
  3. Chronic liver disease,
  4. Diabetes mellitus,
  5. Malignant disease,
  6. Nephrotic syndrome,
  7. Lack of compliance,
  8. Unwillingness til participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00438295


Locations
Denmark
Holstebro Hospital
Holstebro, Denmark, 7500
Sponsors and Collaborators
Regional Hospital Holstebro
Investigators
Study Chair: Erling B Pedersen, Professor Regional Hospital Holstebro

ClinicalTrials.gov Identifier: NCT00438295     History of Changes
Other Study ID Numbers: MED.RES.2007.03.EBP
First Posted: February 22, 2007    Key Record Dates
Last Update Posted: September 15, 2015
Last Verified: September 2007

Keywords provided by Regional Hospital Holstebro:
glucose in dialysis water, dialysis treatment, temperature

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Failure, Chronic
Kidney Diseases
Urologic Diseases
Renal Insufficiency, Chronic